Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT-Reference-Cited by-同舟云学术

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

Published:2013-11-11 Issue:11 Volume:85 Page:1183-1189
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:Journal of Neurology, Neurosurgery & Psychiatry

Author:

Edan G.,Kappos L.,Montalban X.,Polman C. H.,Freedman M. S.,Hartung H.-P.,Miller D.,Barkhof F.,Herrmann J.,Lanius V.,Stemper B.,Pohl C.,Sandbrink R.,Pleimes D.,

Publisher

BMJ

Subject

Psychiatry and Mental health,Neurology (clinical),Surgery

Reference18 articles.

1. Multiple sclerosis;Noseworthy;N Engl J Med,2000

2. Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study;Ebers;Clin Ther,2009

3. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study;Kappos;Lancet,2007

4. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial;Kappos;Lancet Neurol,2009

5. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes;Kappos;Neurology,2006

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring of the pharmacological treatment availability in patients with multiple sclerosis in the Greater Poland population;Rheumatology;2024-01-18

2. Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies;Therapeutic Advances in Neurological Disorders;2024-01

3. Immunity impacts cognitive deficits across neurological disorders;Journal of Neurochemistry;2023-10-29

4. Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating Event;Neurology;2023-09-26

5. Predictive factors of multiple sclerosis relapse after the first demyelinating event: A 5-year follow-up;Multiple Sclerosis and Related Disorders;2023-03